StockVS

The Pennant Group, Inc. (PNTG) Analyse boursière

Santé

The Pennant Group, Inc.

$33.92

+$0.00 (+0.00%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Analyse

Présentation de l'entreprise

The Pennant Group, Inc. operates within the healthcare sector, specifically focusing on the Medical Care Facilities industry by delivering essential services across the United States. Its business model is structured around two primary segments: Home Health and Hospice Services, which provide clinical interventions such as nursing, speech, occupational, and physical therapy, alongside a Senior Living Services segment that supports elderly care needs. The company currently maintains a market capitalization of $1.03 billion and employs a workforce of 9,700 individuals to support its extensive service delivery network. With an annual revenue of $947.71 million, the valuation indicates that the market assigns a significant premium to the entity, reflecting investor confidence in its established operational footprint and the consistent demand for home-based and senior living healthcare solutions within the current economic landscape.

Santé financière

The company reported a total revenue of $947.71 million over the trailing twelve-month period, generating a net income of $29.58 million and an EBITDA of $59.93 million. The substantial disparity between the revenue figure and the net income highlights a cost structure where operational expenses, including cost of goods sold and administrative overhead, consume a significant portion of top-line earnings before reaching the bottom line. Free cash flow stands at $7.21 million, a metric that suggests limited immediate financial flexibility for aggressive expansion or heavy capital expenditure without external financing. When analyzing profitability efficiency, the gross margin sits at 20.0%, indicating that roughly one-fifth of revenue remains after direct costs; the operating margin of 6.2% reveals the efficiency of core business operations before interest and taxes; and the profit margin of 3.1% demonstrates the final portion of revenue retained as earnings after all expenses. The balance sheet presents a leveraged profile with total debt of $459.82 million against cash reserves of $17.02 million, resulting in a debt-to-equity ratio of 122.86%. This high leverage ratio implies that the company relies heavily on borrowed capital relative to shareholder equity, which increases financial risk during periods of rising interest rates. Liquidity is assessed via a current ratio of 1.14, suggesting that for every dollar of current liabilities, the company holds $1.14 in current assets, which is a tight but acceptable buffer for short-term obligations. Management effectiveness is further scrutinized through return metrics, where the return on equity is 9.8% and the return on assets is 3.9%, indicating that the company generates moderate returns on the capital invested by shareholders and a lower return on the total asset base due to its capital-intensive nature.

Évaluation de la valorisation

Valuation multiples for The Pennant Group, Inc. show a trailing P/E ratio of 35.52 compared to a forward P/E of 19.02, implying that the market expects earnings to grow significantly in the coming year to justify the current high multiple. The price-to-book ratio is 3.13, which indicates that the stock trades at a substantial premium of over three times its tangible book value, reflecting expectations of superior future growth or intangible asset strength. Alternative valuation metrics such as the price-to-sales ratio of 1.09 and an EV/EBITDA of 25.34 provide additional context, suggesting that the company is valued at roughly equal to its sales and at a high multiple of its earnings before interest, taxes, depreciation, and amortization relative to peers. Regarding price momentum, the stock has a 52-week high of $35.00 and a 52-week low of $21.73; assuming a current market context within this range, the price action reflects recent volatility and trading dynamics relative to these established benchmarks. The beta value is 1.28, meaning the stock exhibits higher volatility than the broader market, as it tends to move 28% more than the overall market index during periods of fluctuation.

Growth & Income

The company demonstrates robust expansion with revenue growth of 53.2% year-over-year and earnings growth of 53.7% year-over-year. Since earnings growth slightly outpaces revenue growth, this implies potential pricing power or cost efficiencies that are allowing net income to expand at a faster rate than the top line. As the dividend yield is N/A and the payout ratio is 0.0%, the company currently does not distribute cash to shareholders and instead retains earnings to fund operations or growth initiatives. Consequently, the overall growth and income profile for The Pennant Group, Inc. is characterized by aggressive reinvestment of profits rather than income generation through dividends, catering to growth-oriented investors rather than those seeking current yield.

Comparaison avec les pairs

The Pennant Group, Inc. (PNTG) opère dans le secteur Établissements de Soins Médicaux. Voici comment il se compare à ses pairs les plus proches par capitalisation boursière :

Entreprise Ticker Cap. Boursière Ratio P/E
The Pennant Group, Inc. PNTG $1.18B 39.4
HCA Healthcare, Inc. HCA $87.05B 13.5
Tenet Healthcare Corporation THC $15.19B 9.2
DaVita Inc. DVA $12.55B 18.8

Le ratio P/E moyen du secteur Établissements de Soins Médicaux est de 28.6x. The Pennant Group, Inc. se négocie à un P/E de 39.4.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de The Pennant Group, Inc.

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.

La description de l'entreprise est affichée en anglais.

Visiter le site →

Statistiques Clés

Capitalisation
$1.18B
Ratio P/E
39.44
Plus Haut 52 Sem.
$37.54
Plus Bas 52 Sem.
$21.73
Volume Moyen
267.52K
Bêta
1.28

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NASDAQ
Pays
United States
Employés
9,700